PSA

Is Alkaline Phosphatase A Bio-Marker To Predict PSA Decline And Clinical Benefit From Abiraterone Acetate in Bone Metastatic Castration Resistant Prostate Cancer

Again and again I have mentioned the huge need we have for the development of reliable bio-markers. Reliable bio-markers will allow us to know which men will respond positively to a treatment (also those who will not) and when a treatment is still effective (also when it no longer is effective). These biomarkers really don’t [...]

By |2017-10-19T10:46:07-04:00August 17th, 2016|abiraterone acetate, Advanced Prostate Cancer, biomarkers, Biomarkers and Prognostic Tools, Bone Metastases, Bones and Prostate Cancer, Drugs & Treatments, prognostic tools, PSA, Uncategorized, Zytiga|0 Comments
Read More

Flawed Study Shows A Sharp Rise in Advanced Prostate Cancer

Yesterday’s post described research performed at Northwestern University that found a sharp increase in the number of men diagnosed with advanced aggressive prostate cancer between 2004 and 2013. The research interpretation raised the possibility that the United States Preventive Task Force (USPTF) decision to recommend against the use of the